Healthcare Industry

Everything Old is New Again?

National Community Pharmacists Association (NCPA) CEO Douglas Hoey recently wrote an op-ed piece for Morning Consult on behalf of independent pharmacies. In the piece he gives a thoughtful reminder about some of the personalized services that independent pharmacies have been providing patients for years – despite mergers and mail order making headlines regarding their “new” services.…

Read More

President Trump Legalizes Hemp with Farm Bill Signing

On Thursday, Dec. 20, President Trump signed the 2018 Farm Bill into law. The bill passed out of the House last week with a vote of 369-47 and passed the Senate on Tuesday with an 87-13 vote. Among its many agricultural measures, the bill removes hemp from the Controlled Substances Act – effectively legalizing hemp…

Read More

NCOIL Approves Model State PBM Regulation

On Saturday, Dec. 10, the National Conference of Insurance Legislators (NCOIL) approved model legislation for states looking to address unfair PBM practices. The model act, known as the Pharmacy Benefits Manager Licensure and Regulation Model Act, aims to address PBM regulation on the state level in a variety of ways. Kansas Rep. Willie Dove was…

Read More

Changes to DIR Fees Featured in CMS’ Proposed Rule for 2020

On Monday, Nov. 26, 2018, the Centers for Medicare & Medicaid Services (CMS) released their proposed rule for 2020 titled Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses. The proposed rule supplements President Trump’s Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs that was released in May 2018…

Read More

President Signs Opioid Legislation into Law

Today, President Trump signed the SUPPORT for Patients and Communities Act into law to further address the nation’s ongoing opioid crisis. According to the Centers for Disease Control and Prevention (CDC), more than 49,000 people died from opioid overdose in 2017. The bill, which passed out of Congress with bipartisan support, is aimed to help…

Read More

President Signs ‘Gag Clause’ Bills into Law

Today, President Trump signed two bills into law that will allow pharmacists to disclose the lowest cost of prescriptions to their patients. Previously, pharmacy benefit managers (PBMs) have enforced so-called “gag clauses” that prohibited pharmacists from informing their patients if they could purchase their prescriptions for a lower cost out-of-pocket vs. through insurance. The Patient…

Read More

Bills Banning Pharmacy ‘Gag Clauses’ Head to President’s Desk

Yesterday, the House of Representatives unanimously passed two bills that would prohibit “gag clauses” by health insurers and pharmacy benefit managers (PBMs). Gag clauses prohibit pharmacists from preemptively informing customers if their prescription would cost less if they paid out of pocket versus paying through insurance. The Patient Right to Know Drug Prices Act and the Know…

Read More

Senate passes bill banning pharmacy ‘gag clauses’ for Medicare Part D

Last Wednesday, the Senate unanimously passed a bill designed to stop the restrictions and PBM threats tied to “gag clauses” in Medicare Part D plans. The bill, also known as the Know the Lowest Price Act, would allow pharmacists to inform their Medicare Part D patients if the cash price for a prescription is lower than…

Read More

CDC Publishes National Diabetes Prevention Guide for Community Pharmacists

Pharmacies taking part in diabetes prevention just became easier now that the Centers for Disease Control and Prevention has published a new guide called “Rx for the National Diabetes Prevention Program Action Guide for Community Pharmacists.” The guide was developed by CDC’s Division of Diabetes Translation along with pharmacists and pharmacy partners across the country,…

Read More